Why the study?
Does twice-daily timolol reduce blood pressure and plasma renin activity in patients with mild or moderate hypertension?
Does twice-daily timolol reduce blood pressure and plasma renin activity in patients with mild or moderate hypertension?
Twice-daily timolol is effective for mild to moderate hypertension and suppresses plasma renin, with an elimination half-life of 4.7 hours at steady state.
Answers are grounded in this paper and cite their sources.
May support twice-daily timolol in mild hypertension; leaves open confirmation in larger trials.
Timolol given on a twice-daily schedule has shown both antihypertensive effectiveness and plasma renin-suppressing action in eight patients with mild or moderate hypertension. However, the causal relationship between the drug plasma level, blood pressure fall, and change in plasma renin activity was not so clearly demonstrated in the present study. The disposition profiles of timolol at the steady state show an elimination half-life of 4.7 +/- 0.7 hours and a total plasma clearance of 225 +/- 21 ml/min. These values are found to be different from those of our previous observations obtained in normal individuals. Although the range of mean timolol concentrations at steady state varies to a certain extent among different patients, the dosage regimens for patients who will receive treatment for certain chronic disease states (e.g., arrythmias, obstructive cardiomyopathy, and angina pectoris, but not hypertension) in relation to plasma levels should be based on the disposition data obtained under steady state conditions. Bronchospasm developed in one of eight patients whose timolol level was found to be higher than the average of other patients given the same dosage.
No takes yet. Share an insight, caveat, or question.
Ishizaki et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: